News Industry News BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle June 27, 2016
News Industry News BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure May 17, 2016
News Industry News BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment May 16, 2016
News Industry News BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology December 13, 2015
News Industry News BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode December 08, 2015
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Industry News First BioVentrix Revivent® System Clinical Patients Sustain 39.6% Improvement in Heart Function at One Year June 27, 2013
News Industry News Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG January 27, 2013